Company intelligence / Profile preview

Dominion Healthcare

Manchester, England, United Kingdom

Ownership: Private
Development stage: Other

Overview

Dominion Biotech provides predictive preclinical drug screening and immune-oncology model services using patient-derived cell (PDC) assays, including 3D tumoroids and autologous immune cell co-cultures, designed to improve clinical trial decision-making and translation.

Therapeutic areas: Oncology
Modalities: Patient-derived cell model3D tumoroid modelImmunotherapy testing platform
Industry: Drug Discovery Services

Partnerships

Leading cancer hospitals and research collaborators in UK and Europe

Beyond the preview

Go deeper on Dominion Healthcare.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dominion Healthcare.

Explore the full profile